Osteopore (ASX:OSX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Osteopore (ASX:OSX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Half Yearly Report and Accounts
Osteopore reports 8% revenue decline, 14% higher loss, expands global partnerships
OSX strikes orthopaedic deal for 5 Middle East countries
Osteopore expands orthopaedic product distribution into Middle East via 3-year deal with Al-Umnia
Details of Auditor Appointment/Resignation
OSX completes first Hainan custom orthopaedic implant
Activities Report June 2026 and Appendix 4C
Osteopore reports AUD 676K Q2 revenue, secures regulatory approvals and expands market access in Asia
Application for quotation of securities - OSX
First OSX custom orthopaedic implant delivered to Hainan
OSX & Zimmer gain craniofacial market access to Saudi Arabia
OSX completes co-development project for neurosurgical guide
First patient treated in OSX-PAH jaw reconstruction trial
First 2 patients treated in QCH cleft lip clinical trial
QCH cleft lip clinical study patient recruitment completed
OSX neuro products approved in a major centre in Thailand
Cleansing Notice
Notification regarding unquoted securities - OSX
Further Drawdown of T2 of the Redeemable Convertible Notes
Osteopore completes further A$250,000 drawdown of Tranche 2 convertible notes
First OSX custom orthopaedic implant completed in Hong Kong
OSX & DKSH Malaysia dental launch First products delivered
Notification of cessation of securities - OSX
Becoming a substantial holder
Ceasing to be a substantial holder
Application for quotation of securities - OSX
OSX & QCH launch trial for nasoalveolar augment in children